Mongolia vs United Arab Emirates: Immunization, Hib3
Mongolia
96.0%
in 2024
United Arab Emirates
96.0%
in 2024
Mongolia rank
46th
United Arab Emirates rank
46th
Immunization, Hib3 over time
- Mongolia
- United Arab Emirates
How they compare
Mongolia currently reports 96.0% against 96.0% in United Arab Emirates, a difference of 0.0%.
The two have swapped places 6 times across 20 shared years of data; in 2005 it was United Arab Emirates ahead.
Mongolia ranks 46th and United Arab Emirates ranks 46th of 191 countries.
Across the 3 decades both report, Mongolia averaged higher in 2 and United Arab Emirates in 1.
Head to head by decade
| Decade | Mongolia | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.0% | 92.6% | 21.6% | United Arab Emirates |
| 2010s | 98.5% | 97.6% | 0.9% | Mongolia |
| 2020s | 95.6% | 94.8% | 0.8% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Mongolia or United Arab Emirates?
- Mongolia, at 96.0% against 96.0% in United Arab Emirates as of 2024.
- What is the difference in immunization, hib3 between Mongolia and United Arab Emirates?
- 0.0%, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and United Arab Emirates?
- 20 years are reported by both, from 2005 to 2024.
- How do Mongolia and United Arab Emirates rank globally for immunization, hib3?
- Mongolia ranks 46th and United Arab Emirates ranks 46th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.